Efficacy and mechanism of the XPO1 inhibitor selinexor combined with decitabine in T-cell lymphoblastic lymphoma. Meng M, Feng X, Zhang Y, Gao Y, et al. Ann Hematol 2025;104:1747-1756.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Meng M, Feng X, Zhang Y, Gao Y, et al. Efficacy and mechanism of the XPO1 inhibitor selinexor combined with decitabine in T-cell lymphoblastic lymphoma. Ann Hematol 2025;104:1747-1756.
PMID: 40014082